Overview
MRSA at the Bedside
A patient may carry methicillin resistant Staphylococcus aureus (MRSA) in the nares or on the skin without being ill, yet the same organism can invade a wound, bloodstream, lung...
REx-PN
REx-PN
A patient may carry methicillin-resistant Staphylococcus aureus (MRSA) in the nares or on the skin without being ill, yet the same organism can invade a wound, bloodstream, lung, or indwelling-device site. The first clinical distinction is therefore colonization versus infection: a positive screening result shows that MRSA is present, while purulence, tissue inflammation, systemic findings, or a positive culture from a suspected infected site support disease. MRSA also changes how care begins. Its resistance limits the usefulness of beta-lactam antibiotics, and transmission commonly occurs through hands, equipment, and contaminated surfaces. Apply contact precautions for suspected as well as confirmed MRSA while diagnostic specimens and susceptibility results are being obtained. If the infection is severe, vancomycin may be required; safe administration depends on the patient’s actual body weight, renal function, serum level plan, and response to the infusion.
Unlock full lesson + practice questions
5 more sections with scenarios, priorities, and review drills.
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this REx-PN pathway. You can still explore topic-filtered questions from the bank hubs below.